Recently, the Hyasen team visited the Oswaldo Cruz Foundation (Fiocruz) in Brazil, engaging in productive discussions and exchanges on biotechnology, diagnostics, innovation, and potential opportunities for future collaboration.
Fiocruz is a federal public foundation linked to Brazil’s Ministry of Health and one of the country’s leading institutions in science, technology, innovation, and public health. With extensive capabilities in scientific research, technological development, healthcare, education, and the development and production of health-related solutions, Fiocruz plays an important role in supporting Brazil’s public health system and advancing health innovation.
During the visit, the Hyasen team gained deeper insights into Fiocruz’s work in public health, biotechnology, diagnostic technologies, and scientific innovation. The two sides exchanged perspectives on industry development, emerging technologies, product quality, supply chain reliability, and the evolving needs of the global healthcare sector.
Photo 1: Hyasen and Fiocruz representatives exchange perspectives on biotechnology, diagnostics, and public health.
The discussions also provided an opportunity to explore areas of mutual interest and potential future cooperation. As healthcare systems worldwide continue to place greater emphasis on reliable diagnostics, innovative biotechnology solutions, and resilient supply chains, closer communication between industry and public health institutions can contribute to the development of more accessible and sustainable healthcare solutions.
As a global biotechnology company, Hyasen focuses on providing core enzymes and reagents for molecular diagnostics, biopharmaceutical materials, laboratory products, and related life science solutions. With a strong commitment to quality, innovation, and global collaboration, Hyasen continues to support customers and partners across the diagnostics, biotechnology, pharmaceutical, and healthcare industries.
The visit to Fiocruz marks another meaningful step in Hyasen’s continued engagement with leading healthcare and scientific institutions worldwide. It also reflects Hyasen’s commitment to strengthening its presence in Brazil and the broader Latin American market through closer communication, technical exchange, and long-term partnerships.
Hyasen sincerely appreciates the warm welcome and valuable discussions during the visit to Fiocruz. We look forward to maintaining close communication and exploring further opportunities for collaboration in biotechnology, diagnostics, and public health.
About Hyasen
Photo 2: Hyasen representatives with the Fiocruz team during the visit.
Hyasen is a biotechnology company dedicated to providing high-quality products and solutions for the global life science and healthcare industries. Its portfolio covers core enzymes and reagents for molecular diagnostics, biopharmaceutical materials, laboratory products, and related biotechnology solutions.Through continuous innovation and global collaboration, Hyasen aims to support partners worldwide with reliable products, professional services, and comprehensive solutions that contribute to advances in diagnostics, biotechnology, and human health.
Through continuous innovation and global collaboration, Hyasen aims to support partners worldwide with reliable products, professional services, and comprehensive solutions that contribute to advances in diagnostics, biotechnology, and human health.
